Vladimir Vimberg

677 total citations
21 papers, 473 citations indexed

About

Vladimir Vimberg is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Vladimir Vimberg has authored 21 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Infectious Diseases and 8 papers in Genetics. Recurrent topics in Vladimir Vimberg's work include RNA and protein synthesis mechanisms (11 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Bacterial Genetics and Biotechnology (8 papers). Vladimir Vimberg is often cited by papers focused on RNA and protein synthesis mechanisms (11 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Bacterial Genetics and Biotechnology (8 papers). Vladimir Vimberg collaborates with scholars based in Czechia, Estonia and Sweden. Vladimir Vimberg's co-authors include Tanel Tenson, Maido Remm, Gabriela Balíková Novotná, Jiřı́ Janata, Martin Lovmar, Karin Nilsson, Måns Ehrenberg, Jonas Löfling, Patrick Bättig and Birgitta Henriques‐Normark and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and International Journal of Molecular Sciences.

In The Last Decade

Vladimir Vimberg

21 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vladimir Vimberg Czechia 12 313 102 72 70 64 21 473
Karen O’Dwyer United States 9 274 0.9× 64 0.6× 76 1.1× 53 0.8× 76 1.2× 12 456
Nathalie Josseaume France 12 274 0.9× 148 1.5× 101 1.4× 41 0.6× 167 2.6× 17 517
Daniela Vollmer United Kingdom 8 150 0.5× 97 1.0× 61 0.8× 23 0.3× 70 1.1× 17 332
Sebastian Kuhn Germany 8 243 0.8× 61 0.6× 70 1.0× 25 0.4× 148 2.3× 9 402
Akihiro Doi Japan 8 273 0.9× 148 1.5× 96 1.3× 19 0.3× 99 1.5× 14 447
Beatriz Llano-Sotelo United States 7 334 1.1× 78 0.8× 115 1.6× 61 0.9× 68 1.1× 8 473
Joenel Alcantara Canada 11 295 0.9× 57 0.6× 27 0.4× 46 0.7× 40 0.6× 16 522
Britta E. Rued United States 8 167 0.5× 84 0.8× 34 0.5× 20 0.3× 34 0.5× 12 295
Jitender Mehla United States 13 241 0.8× 60 0.6× 79 1.1× 30 0.4× 49 0.8× 21 426
Christian Hulen France 12 253 0.8× 61 0.6× 62 0.9× 26 0.4× 39 0.6× 28 366

Countries citing papers authored by Vladimir Vimberg

Since Specialization
Citations

This map shows the geographic impact of Vladimir Vimberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Vimberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Vimberg more than expected).

Fields of papers citing papers by Vladimir Vimberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Vimberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Vimberg. The network helps show where Vladimir Vimberg may publish in the future.

Co-authorship network of co-authors of Vladimir Vimberg

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Vimberg. A scholar is included among the top collaborators of Vladimir Vimberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Vimberg. Vladimir Vimberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sur, Vishma Pratap, et al.. (2022). Dynamic study of small toxic hydrophobic proteins PepA1 and PepG1 of Staphylococcus aureus. International Journal of Biological Macromolecules. 219. 1360–1371. 6 indexed citations
3.
Sur, Vishma Pratap, Aninda Mazumdar, Vladimir Vimberg, et al.. (2021). Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics. International Journal of Molecular Sciences. 23(1). 97–97. 7 indexed citations
4.
Vimberg, Vladimir, et al.. (2021). Two Novel Semisynthetic Lipoglycopeptides Active against Staphylococcus aureus Biofilms and Cells in Late Stationary Growth Phase. Pharmaceuticals. 14(11). 1182–1182. 1 indexed citations
5.
Vimberg, Vladimir. (2021). Teicoplanin—A New Use for an Old Drug in the COVID-19 Era?. Pharmaceuticals. 14(12). 1227–1227. 16 indexed citations
6.
Vimberg, Vladimir, Karolína Buriánková, Aninda Mazumdar, Pavel Branny, & Gabriela Balíková Novotná. (2021). Role of membrane proteins in bacterial resistance to antimicrobial peptides. Medicinal Research Reviews. 42(3). 1023–1036. 8 indexed citations
7.
Vimberg, Vladimir, et al.. (2020). VanZ Reduces the Binding of Lipoglycopeptide Antibiotics to Staphylococcus aureus and Streptococcus pneumoniae Cells. Frontiers in Microbiology. 11. 566–566. 21 indexed citations
8.
Vimberg, Vladimir, et al.. (2020). Ribosome-Mediated Attenuation of vga (A) Expression Is Shaped by the Antibiotic Resistance Specificity of Vga(A) Protein Variants. Antimicrobial Agents and Chemotherapy. 64(11). 17 indexed citations
9.
Vimberg, Vladimir, et al.. (2019). Draft genome sequences of three clinical isolates of teicoplanin-resistant Staphylococcus epidermidis from patients without prior exposure to glycopeptide antibiotics. Journal of Global Antimicrobial Resistance. 16. 251–253. 2 indexed citations
10.
Insuasty, Alberto, Juan Guzman, Oscar M. Vidal, et al.. (2019). New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity. European Journal of Medicinal Chemistry. 176. 50–60. 69 indexed citations
11.
Vimberg, Vladimir, Radek Gažák, Anikó Borbás, et al.. (2018). Fluorescence assay to predict activity of the glycopeptide antibiotics. The Journal of Antibiotics. 72(2). 114–117. 11 indexed citations
12.
Vimberg, Vladimir, Jorunn Pauline Cavanagh, Oldřích Benada, et al.. (2017). Teicoplanin resistance in Staphylococcus haemolyticus is associated with mutations in histidine kinases VraS and WalK. Diagnostic Microbiology and Infectious Disease. 90(3). 233–240. 8 indexed citations
13.
Vimberg, Vladimir, Marek Kuzma, Eva Stodůlková, et al.. (2015). Hydnocarpin-Type Flavonolignans: Semisynthesis and Inhibitory Effects on Staphylococcus aureus Biofilm Formation. Journal of Natural Products. 78(8). 2095–2103. 17 indexed citations
14.
Vimberg, Vladimir, et al.. (2014). Detailed Mutational Analysis of Vga(A) Interdomain Linker: Implication for Antibiotic Resistance Specificity and Mechanism. Antimicrobial Agents and Chemotherapy. 59(2). 1360–1364. 26 indexed citations
15.
Löfling, Jonas, Vladimir Vimberg, Patrick Bättig, & Birgitta Henriques‐Normark. (2010). Cellular interactions by LPxTG-anchored pneumococcal adhesins and their streptococcal homologues. Cellular Microbiology. 13(2). 186–197. 46 indexed citations
16.
Lovmar, Martin, et al.. (2009). Erythromycin resistance by L4/L22 mutations and resistance masking by drug efflux pump deficiency. The EMBO Journal. 28(6). 736–744. 31 indexed citations
17.
Lovmar, Martin, et al.. (2009). Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycin. Biochimie. 91(8). 989–995. 11 indexed citations
18.
Vimberg, Vladimir, et al.. (2007). Translation initiation region sequence preferences in Escherichia coli. BMC Molecular Biology. 8(1). 100–100. 85 indexed citations
19.
Lovmar, Martin, Karin Nilsson, Vladimir Vimberg, et al.. (2006). The Molecular Mechanism of Peptide-mediated Erythromycin Resistance. Journal of Biological Chemistry. 281(10). 6742–6750. 35 indexed citations
20.
Vimberg, Vladimir, et al.. (2004). Peptide‐mediated macrolide resistance reveals possible specific interactions in the nascent peptide exit tunnel. Molecular Microbiology. 54(2). 376–385. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026